Biogen INC BIOGEN INC ORD SHS/ US09062X1037 /
24.05.2024 18:25:10 | Diff. - | Volumen | Geld06:00:09 | Brief06:00:09 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
218,75USD | - | 1.014 Umsatz: 110.398,48 |
-Geld Vol: - | -Brief Vol: - | 29,83 Mrd.USD | - | 25,53 |
Aktiva
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 1.750,7000 | 1.765,6830 | 2.187,6000 | 2.501,8000 | 3.182,4000 | ||||||
Immaterielle Vermögensgegenstände | 4.474,7000 | 4.028,5070 | 4.085,1000 | 3.808,3000 | 3.879,6000 | ||||||
Finanzanlagen | 625,8000 | 1.470,6520 | 2.760,4000 | 2.829,4000 | 3.057,3000 | ||||||
Anlagevermögen | - | 9.643,8860 | 12.804,5000 | 14.144,6000 | 15.779,3000 | ||||||
Vorräte | 659 | 804,0220 | 893,4000 | 1.001,6000 | 902,7000 | ||||||
Forderungen | 824,4000 | 1.292,4450 | 1.227 | 1.441,6000 | 1.787 | ||||||
Liquide Mitteln | 602,6000 | 1.204,9240 | 1.308 | 2.326,5000 | 1.573,8000 | ||||||
Umlaufvermögen | 3.184,9000 | 4.672,6730 | 6.700,3000 | 8.732,2000 | 7.873,3000 | ||||||
Aktiva, gesamt | 11.863,3000 | 14.316,5590 | 19.504,8000 | 22.876,8000 | 23.652,6000 |
Passiva
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 219,9000 | 229,1780 | 267,4000 | 279,8000 | 395,5000 | ||||||
Langfristige Schulden | 592,4000 | 582,0610 | 6.521,5000 | 6.512,7000 | 5.935 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | 592,4000 | 582,1000 | 6.521,5000 | 6.512,7000 | 5.935 | ||||||
Rückstellungen | 412,3000 | 218,8000 | 333,6000 | 325 | 190,8000 | ||||||
Verbindlichkeiten | 3.242,5000 | 3.502,5190 | 10.129,9000 | 10.748,2000 | 11.054,5000 | ||||||
Gezeichnetes Kapital | - | ,1290 | ,1000 | ,1000 | ,1000 | ||||||
Eigenkapital | 8.620,8000 | 10.814,0400 | 9.374,9000 | 12.128,6000 | 12.598,1000 | ||||||
Minderheitenanteile | ,6000 | 5,0300 | 2,1000 | -11,5000 | -14,7000 | ||||||
Passiva, gesamt | 11.863,3000 | 14.316,5590 | 19.504,8000 | 22.876,8000 | 23.652,6000 |
Gewinn- und Verlustrechnung
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 6.932,2000 | 9.703,3240 | 10.763,8000 | 11.448,8000 | 12.273,9000 | ||||||
Abschreibungen (Gesamt) | 342,9000 | 688,1500 | 600,4000 | 682,7000 | 1.081 | ||||||
Betriebsergebnis | 2.490,6000 | 3.972,4140 | 4.891 | 5.150,4000 | 5.344,2000 | ||||||
Zinsergebnis | - | -17,3000 | -73,4000 | -196,6000 | -172,3000 | ||||||
Ergebnis vor Steuern | 2.480,6000 | 3.946,6330 | 4.767,3000 | 4.933 | 5.128,8000 | ||||||
Ertragsteuern | 601 | 989,9420 | 1.161,6000 | 1.237,3000 | 2.458,7000 | ||||||
Gewinnanteil Minderheitsgesellschafter | 0.0000 | 6,7810 | 46,2000 | -7,1000 | 131 | ||||||
Konzernjahresüberschuss | 1.862,3000 | 2.934,7840 | 3.547 | 3.702,8000 | 2.539,1000 |
Pro Aktie
Cash Flow
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 2.345,1000 | 2.942,1150 | 3.716,1000 | 4.522,4000 | 4.551 | ||||||
Cash Flow aus Investitionstätigkeit | -1.604,7000 | -1.542,9760 | -4.553,6000 | -2.484,8000 | -2.963,1000 | ||||||
Cash Flow aus Finanzierungstätigkeit | -716,5000 | -755,8730 | 986,4000 | -987,8000 | -2.380 | ||||||
Veränderung der liquiden Mittel | 23,9000 | 643,2660 | 148,9000 | 1.049,8000 | -792,1000 | ||||||
Anzahl der Mitarbeiter | 6.850 | 7.550 | 7.350 | 7.400 | 7.300 |